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Abstract: Silk contains a fibre forming protein, fibroin, which is biocompatible, particularly after removing 
the potentially immunogenic non-fibroin proteins. Silk can be engineered into a wide range of materials with 
diverse morphologies. Moreover, it is possible to regenerate fibroin with a desired amount of crystallinity, so 
that the biodegradation of silk materials can be controlled. These advantages have sparked new interest in 
the use of silk fibroin for biomedical applications, including tissue engineering scaffolds and carriers for 
sustained release of biologically active molecules. This article summarizes the current research related to the 
formation of silk materials with different morphologies, their biocompatibility, and examples of their 
biomedical applications. Recent work on the preparation of silk particles by mechanical milling and their 
applications in silk composite scaffolds is also discussed.  
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1. Introduction 
 
Silk consists of fibrous proteins that are stored as a 
liquid in silk producing arthropods (such as silkworms, 
spiders, scorpions, mites and bees) and are spun into 
fibres at secretion [1]. Amongst various silk species, 
silkworm and spider silk fibres have been widely 
studied for their structure, processing, and functional 
properties. About 90% of commercial silk fibres used 
in the textile industry come from Lepidopteron 
silkworms from the family, Bombycidae [2]. In the 
textile industry, it is commonly referred to as Mulberry 
silk. Saturniidae is another class of Lepidopteron 
silkworms that produce commercial silk fibres such as 
Tasar, Eri and Muga.  
Apart from their long history as luxury textiles, silk 
has also been used  in the human body in the form of 
suture material [3]. A study by Minoura et al. [4,5] has 
suggested much wider application prospects for silk. 
Their study showed that silk fibroin of B.mori and 
A.pernyi was equal to or even better than collagen in 
supporting attachment and proliferation of murine L-
929 fibroblast cells. The results have generated 
enormous interest in the ensuing years to examine silk 
fibroin for various biomedical and healthcare 
applications through in-vitro or animal model studies.  
Native silk fibre suture is a Food and Drug 
Administration (FDA, USA) approved biomaterial.   
Recently, regenerated silk has also been approved by 
the FDA for human clinical tests. 
 
2. Different forms of silk biomaterial 
 
Silk biomaterials can be prepared directly from silk 
fibres, or reconstituted from silk fibroin solution.  An 
alternate way is to convert silk fibres into ultrafine 
particles through milling. Figure 1 shows a schematic 
diagram of processing silk fibres into various forms of 
diverse morphologies [6]. 
 
2.1 Native Silk fibre based structures 
 
Degummed silk filaments in the form of twisted 
structures, such as wire-rope, cable, braided, and 
textured yarns have been analysed for potential 
biomedical applications [7]. Silk filaments can also be 
used to construct nonwoven structures as a cell 
supporting template, by partially dissolving silk fibres 
[8,9]. Random arrangements of filaments in a cocoon 
can  be preserved during degumming to design a 
porous nonwoven silk mat for cell seeding [9]. An 
alternate way of using silk filaments directly in tissue 
engineering is making a knitted structure [10]. Such 
knitted structures have been used to reinforce 3-D 
porous tissue engineering scaffolds for improved 
mechanical properties [11].  
2.2 Regenerated Silk Biomaterials 
 
Silk fibres can be dissolved by using a highly 
concentrated solution of chaotropic salts followed by 
dialysis to prepare an aqueous silk solution. 
Alternatively, ionic solvents have been used to dissolve 
silk fibres [12-14]. Silk aqueous solutions form gels 
during prolonged storage (months), particularly when 
silk concentration is high [15]. Hence, silk aqueous 
solutions are normally lyophilized for the purpose of 
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storage and further processing. Lyophilized silk is 
amorphous in nature and can be reconstituted into  
dope using different organic [16-20] or acidic solvents 
[21]. A number of different regenerated products can 
be formed using silk fibroin aqueous solutions or 
reconstituted dope. The following forms of regenerated 
silk have been examined in recent years: 
Figure 1 Process pathways for the different forms of silk biomaterial 
2.2.1 Silk films 
 
Silk fibroin films can be prepared by casting [13,21-
24], spin coating [13], Langmuir-Blodgett (LB) [25] 
and layer by layer deposition [26-28]. Recently, 
patterned silk films have been developed as a  cell 
supporting template for improved cell proliferation 
[13,29]. High oxygen and water vapour permeability of 
silk films is important for their wound healing 
applications [30,31]. 
 
2.2.2 Regenerated silk fibres 
 
Electrospinning has been used to create silk nonwoven 
mats with a large surface area and a porous structure  
 
that are useful for cell seeding [32,33] and as 
separation membranes [34]. More recently, 3-D 
constructions of silk nanofibres have been used as 
blood vessel grafts and nerve guides [35,36]. Likewise, 
wet spinning of silk has been examined to produce silk 
fibres with physical and mechanical properties 
otherwise not available in its natural form. Producing 
regenerated silk with properties comparable to native 
silk fibres has been a major challenge. However, in 
recent years, it has been shown that by appropriate post 
spinning drafting, regenerated silk fibres having 
superior mechanical properties could be produced [37]. 
Likewise, it was also demonstrated that by optimising 
the rate of coagulation during extrusion and through 
post spinning stream annealing of extruded fibres, the 
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fibre properties could be significantly improved. Fibres 
which are finer and tougher than native silk have also 
been prepared [38]. 
 
2.2.3 Silk hydrogel 
 
Hydrogels are three-dimensional polymer networks 
useful for encapsulation and delivery of biologically 
relevant agents. Silk hydrogels can be formed through 
sol–gel transition of aqueous silk fibroin solutions in 
the presence of acids, dehydrating agents, and ions [39-
42]. Recently, silk hydrogels have been formed using 
ultrasonic energy [43].  
 
2.2.4 3-D porous scaffold 
 
Porous 3-D sponges are ideal structures for tissue 
engineering scaffolds as they provide an environment 
quite similar to the in-vivo microenvironment for cells 
to grow into various tissues. Silk 3-D porous scaffolds 
have been prepared using freeze drying, porogen 
leaching, and solid freeform fabrication techniques 
[44-48]. Due to the success in achieving good control 
over porosity and pore size, the development of 
porogen leached 3-D silk scaffolds has continued 
during the last few years for a number of tissue 
engineering applications, predominantly for bone and 
cartilage applications [49-57].  
 
2.2.5 Silk particles 
 
In the past, silk particles were prepared from aqueous 
silk solutions either by dehydration followed by 
pulverisation [58] or by spray drying [59,60]. In order 
to control the particle size and morphology and also to 
further reduce particle sizes, new techniques have been 
examined in recent years. These include self assembly 
[61-63], phase separation [64,65], or rapid expansion 
of supercritical fluid solution. 
 
3. Biologically relevant properties of silk 
biomaterials 
 
In addition to the ability to fabricate diverse 
morphologies, studies in recent years have confirmed 
that the following properties of silk biomaterials are 
important for their applications as advanced 
biomaterials. 
 
 
 
 
3.1 Slow and tuneable biodegradation 
 
Silk is a biodegradable material. The rate of 
biodegradation of silk depends on its structure and 
morphology. For example, Arai et al. [66] 
demonstrated that native silk fibres degrade slowly and 
the degradation depends on the diameter of the silk 
fibre [67]. Wang et al. [68] examined in-vivo 
degradation behaviour of silk porous scaffolds. Their 
studies revealed that by changing the processing 
method (aqueous vs. organic solvent) and processing 
variables (silk fibroin concentration and pore size in 
scaffolds), short-term (up to 2 months) and long-term 
(up to 1 year) in-vivo degradation could be altered. 
Other  studies on the degradation of silk showed that 
processing solvents [24,46] and the annealing methods 
[69] could also influence biodegradation of silk. These 
studies indicate predictable degradation behaviour of 
silk which is highly desirable for biomedical 
applications. 
 
3.2 Biocompatibility 
 
All non-autologous biomaterials result in some foreign 
body response when interacting with living tissues. 
Despite their longstanding use as suture materials, 
including the successful embolization of cerebral 
arteriovenous malformations [70, 71], some adverse 
immunological events have been associated with silk 
proteins. Such problems are now linked to the presence 
of silk gum (sericin) [72] or one or more non fibroin 
components, which can be removed while preparing 
silk based biomaterials [73]. There  are still some 
concerns that fibroin itself may also cause delayed 
hypersensitivity, but admittedly only in rare cases [74]. 
Multiple studies with silk biomaterials, such as fibres 
[75], micro-fibrous meshes [8], nonwoven mats [8,76], 
films [25,77,78], hydrogels [42], and 3-D sponge [68],  
have shown only mild foreign body response in some 
cases when studied in-vitro [8,25,42,72,75,77,79]. 
Similarly, cytotoxicity was found to be very low in 
animal model studies [8,68,76,78]. Overall, there has 
been widespread acceptance that properly degummed 
and sterilised silk products are biocompatible and 
comparable with other commonly used biomaterials, 
such as polylactic acid (PLA) and collagen [72,80]. 
Some studies even suggest that, compared to collagen 
coatings, silk coatings have superior ability over 
synthetic biomaterials to reduce the expression of pro-
inflammatory cytokines, like IL-1β, TNF-α, or TGF-β1 
[81,82], and also reduce thrombogenesis [83]. 
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4. Targeted biomedical applications 
 
4.1 Wound healing and tissue engineering 
 
In 2000, Sugihara et al. [84]  showed that wound 
healing was much faster with silk films than 
conventional hydrocolloid dressing
 
(Duro Active). 
Their histological findings revealed greater collagen 
regeneration and less inflammatory response in the 
case of silk. Other silk materials, such as nonwoven 
mats [76], hydrogels [85], and electro-spun silk fibroin 
mats [86] have also shown promises as wound healing 
materials. In recent years, silk has been widely studied 
for tissue engineering applications. Host cells are pre-
seeded in scaffolds followed by implantation in the 
damaged site of the body. Silk scaffolds have been 
extensively used for the regeneration of 
musculoskeletal tissues, such as bone and cartilage 
with promising results [87-89]. For example, Meinel et 
al. [53,55] showed that silk 3-D scaffolds with pre-
differentiated (osteogenic) hMSCs could support 
healing critical size femoral segment defects and 
calvarial critical sized defects in nude rats and mice, 
respectively. 3-D scaffolds exhibited good osteogenic 
potential, almost bridging the defects with new bone 
after 8 weeks and exhibited good load-bearing 
capabilities and torque when compared to their other 
experimental and control groups [53].  Incorporation of 
BMP-2 in scaffolds could further accelerate the healing 
of bone defects in animals with or without pre-
differentiated hMSCs [54]. In addition, 3-D porous 
scaffolds showed promising results for cartilage tissue 
engineering [9,56,57,90] and generation of bone and 
cartilage at the same time [91].  
 
 
Figure 2 Human Tympanic membrane keratinocytes 
growth on silk fibroin membrane: (i) Light microscopy 
image of day 18 [99]; (ii) Confocal microscopy image 
of cells immunofluorescently stained with occludin 
(green) and ZO-1 (red). Cell nuclei are counterstained  
with DAPI (blue) [100]. 
 
Other tissue engineering studies  with silk for repair 
of specific defects include regeneration of ligament 
[7,11,92], peripheral nerve [79], skin [93,94], cornea 
[29,95], ear drum [96], and trachea [97]. Recently, 
Lovett et al. used silk fibroin for the construction of 
microvascular grafts [98]. Tissue engineered silk sling 
for the treatment of stress urinary incontinence has also 
been reported [10]. Silk membranes have been used for 
the growth of human tympanic membrane (TM) 
kerotinocytes [99]. Figure 2 presents images of TM 
keratinocytes grown on such silk films. 
 
4.2 Immobilisation and delivery of 
drugs/enzymes  
 
Mild aqueous processing of silk is advantageous for 
loading sensitive drugs without affecting their 
functions. For example, Lu et al. studied glucose 
oxidase, lipase, and horseradish peroxidise entrapped 
in silk films and found that for over 10 months, 
enzymes retained their significant activity, even when 
stored at 37
0
C, and in the case of glucose oxidase, they 
did not lose any activity [101]. Release kinetics of 
drugs and enzymes is reported to depend, to a large 
extent, on the content of crystalline β-sheets [28,61, 
102,103].  
Silk has been used for the control release of specific 
drugs for targeted clinical needs. Uebersax et al. [104] 
and Szybala et al.[105] used silk matrices as 
adenosine-releasing bioincubators that may be useful 
in the management of epilepsy. Recently, Pritchard et 
al. demonstrated that slow (up to 2 weeks) and linear 
release of adenosine was possible by controlling the 
thickness and cystrallinity of silk coatings [105]. 
Bayraktar et al. [106] used aqueous silk solutions to 
coat theophylline tablets. It was shown that slow 
release by multilayered silk coatings could enhance the 
efficacy of delivering emodin, an anti breast cancer 
and anti tumour drug [107,108]. Numata and Kaplan 
have recently reviewed silk-based multi-block 
copolymer systems as vehicles for sustained release of 
small molecule drugs, proteins and genes [109]. 
Silk particles have also been examined for potential 
drug delivery applications.  Lorenz Meinel’s group 
reported encapsulation and release of horseradish 
peroxidase (HRP) using self assembled silk 
microspheres [61]. They also reported encapsulation of 
salicylic acid, propranolol hydrochloride, and 
recombinant human insulin growth factor I (IGF-I) in 
silk microspheres. Encapsulation efficiency of IGF-I 
was close to 100%. They also used BMP-2 and IGF-I 
loaded silk microspheres in silk porous scaffolds and 
obtained enhanced osteochondral tissue engineering 
outcomes [91]. 
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Silk’s ability to hold therapeutic enzymes can be 
combined with the change in optical response of silk to 
design biodegradable and chemically responsive 
implantable optofluidic devices for applications such 
as monitoring changes in blood glucose. Domachuk et 
al. incorporated hemoglobin into free-standing silk 
diffraction gratings and simultaneously immobilized 
enzymes to examine such prospects [110]. 
 
5. Recent advances in silk milling and 
applications of milled silk particles 
 
Developments of silk particles for biomedical 
applications have been mostly restricted to bottom up 
approaches as discussed already. However, top down 
approach of particle preparation through milling has 
comparative advantages as it can avoid the use of 
chemicals and the long dialysis time associated with 
the bottom up methods. The silk powder thus prepared 
should enhance the application scope of silk based 
materials also. 
 
5.1 Silk milling 
 
Silk has a hierarchical structure with fibroin chains 
forming nano fibrils, bundles of which constitute the 
fibre [111-117]. This suggests an opportunity to 
defibrillate silk into nano fibrils and fine particles. 
However, silk being a strong viscoelastic material is 
difficult to mill into fine particles with a controlled 
morphology and a narrow size distribution. Hence, a 
very long milling time (up to 48 hours) is usually 
necessary to obtain maximum possible fineness of 
around 5 µm [118-120]. To overcome such problems, 
pre-treatments such as alkali degradation [118], 
exposure to high temperature [121], radiation 
[122,123], and steam explosion [124,125],  have been 
used to improve the milling efficiency. New 
developments have been reported to improve fine silk 
powder production in recent years.  Li et al. discussed 
preparation of nano silk particles through a multistep 
process which includes a special high pressure device 
and filtering large particles during the process 
[126,127].  
We have recently examined a number of standard 
milling devices to prepare ultrafine silk particles from 
Mulberry and non-Mulberry silk fibres. Milling 
sequences using a combination of milling systems such 
as a cutter mill, a rotary mill, different forms of ball 
mills and an air jet mill were examined [128,129]. We 
observed that non-Mulberry silk fibres which have a 
more porous structure and lower strength could be 
milled more efficiently than mulberry silk [129]. It was 
shown that by appropriate selection of milling 
sequence and milling parameters, milling time could be 
reduced to about 6 hours without any pre-treatment. A 
final step using air jet milling could achieve dry silk 
powder with a volume based median particle size of 
less than 1 μm. Figure 3 shows images of such 
particles. 
  
                      i                                          ii 
 
Figure 3 Wet milled and spray dried silk particles 
 (i) before and (ii) after air jet milling. 
 
5.2 Silk composites with silk particles 
 
Despite excellent biological outcomes, 3-D silk 
scaffolds are not strong enough for load-bearing tissue 
engineering applications. Kim et al. [49] reported that, 
usually, bone-like tissue ingrowth could be seen after 
12 weeks of cell seeding in 3-D silk scaffolds. Such 
bonny tissue deposition could enhance the strength of 
scaffolds, but they were still much weaker (wet 
compressive modulus remained less than 200 kPa and 
yield strength less than 40 kPa) than the natural bone.  
To increase the mechanical properties of silk 
scaffolds, milled silk particles were used as a 
reinforcing agent to fabricate a new silk-silk composite 
system [130]. SEM images of the composites are 
presented in Figure 4. The reinforcing particles 
maintained their crystalline structure in the composites 
[131], but unlike parent fibres, the particles are 
partially soluble in organic solvent, such as 
hexaflouroisopropanol (HFIP) [130]. This provides a 
high interfacial bonding between the particles and the 
bulk phase prepared using HFIP. This mechanism has 
resulted in a substantial increase in mechanical 
properties of silk particle reinforced silk composites 
(Figure 5). This novel silk processing method therefore 
provides a promising option for preparing new silk 
based biomaterials for hard tissue engineering 
applications. Further work is ongoing in this area in 
our laboratory in collaboration with Prof Kaplan’s  
group at Tufts University.
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(i) HFIP based, reinforced with 100% silk particles; 
 
(ii) water based, reinforced with 25% silk particles. 
 
Figure 4 SEM images of 3D silk composite scaffolds 
 
 
 
(i) Compressive load vs. strain curves 
 (porogen size: 500-600 μm); 
(ii) Compressive modulus. 
 
Figure 5 Compressive properties of silk composite scaffolds prepared from 17% HFIP-based silk solution 
reinforced with different % of silk particles[130]. 
 
6. Conclusion 
 
Research into silk materials and their in-vitro and in-
vivo performance for targeted biomedical applications 
has gained much ground over the last few years. This 
has resulted in unique innovations in silk materials 
developed for specific applications. In addition to silk 
fibres and solutions, milled silk particles are now 
expanding the application scope for silk based 
biomaterials.  
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